Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging

The poor prognosis associated with malignant melanoma has not changed substantially over the past 30 years. Targeted molecular therapies, such as immunotherapy have shown promise, but suffer from resistance and off-target toxicities, underscoring the need for alternative therapeutic strategies that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Appl Mater Interfaces
Main Authors: Chen, Feng, Zhang, Xiuli, Ma, Kai, Madajewski, Brian, Benezra, Miriam, Zhang, Li, Phillips, Evan, Turker, Melik Z., Gallazzi, Fabio, Overholtzer, Michael, Pauliah, Mohan, Gonen, Mithat, Zanzonico, Pat, Wiesner, Ulrich, Bradbury, Michelle S., Quinn, Thomas P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803308/
https://ncbi.nlm.nih.gov/pubmed/29058865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsami.7b14362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados